News & Updates
Filter by Specialty:
Azithromycin use poses acute heart failure, mortality risks for some COVID-19 patients
Exposure to azithromycin may put patients with COVID‐19 and history of cardiovascular disease (CVD) at higher risks of acute heart failure and death, as reported in a study.
Azithromycin use poses acute heart failure, mortality risks for some COVID-19 patients
18 Jul 2023
Theophylline shows promise in SCI-induced bradycardia
Use of theophylline as an adjunctive therapy appears to lead to favourable outcomes among patients with bradycardia due to acute spinal cord injury (SCI) with an acceptable response to this agent, suggest the results of a study.
Theophylline shows promise in SCI-induced bradycardia
18 Jul 2023
Advanced liver fibrosis a red flag for poor outcomes in T2D
Among individuals with type 2 diabetes (T2D), the risk of poor outcomes such as heart failure and hospitalizations is high in the presence of advanced liver fibrosis, according to a study.
Advanced liver fibrosis a red flag for poor outcomes in T2D
18 Jul 2023
SGLT2 inhibitors tied to kidney benefits, reduced MACE risk
Treatment with sodium-glucose lowering co-transporter 2 inhibitors (SGLT2i) helps arrest the decline in estimated glomerular filtration rate (eGFR) and is associated with a lower risk of adverse kidney events among adults with diabetes, irrespective of baseline albuminuria status, as shown in a study presented at the recent ADA 2023.